SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-028354
Filing Date
2021-12-13
Accepted
2021-12-13 07:45:24
Documents
34
Period of Report
2021-12-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K navb20211212_8k.htm   iXBRL 8-K 26016
2 EXHIBIT 99.1 ex_315795.htm EX-99.1 11820
3 EXHIBIT 99.2 ex_315794.htm EX-99.2 11781
8 a01.jpg GRAPHIC 162676
9 a02.jpg GRAPHIC 58614
10 a03.jpg GRAPHIC 142676
11 a04.jpg GRAPHIC 52880
12 a05.jpg GRAPHIC 28221
13 a06.jpg GRAPHIC 87546
14 a07.jpg GRAPHIC 28799
15 a08.jpg GRAPHIC 109019
16 a09.jpg GRAPHIC 126579
17 a10.jpg GRAPHIC 129175
18 a11.jpg GRAPHIC 29892
19 a12.jpg GRAPHIC 109485
20 a13.jpg GRAPHIC 32721
21 a14.jpg GRAPHIC 83891
22 a15.jpg GRAPHIC 87448
23 a16.jpg GRAPHIC 61141
24 a17.jpg GRAPHIC 62163
25 a18.jpg GRAPHIC 112709
26 a19.jpg GRAPHIC 57196
  Complete submission text file 0001437749-21-028354.txt   2341493

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA navb-20211213.xsd EX-101.SCH 3594
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20211213_def.xml EX-101.DEF 11808
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20211213_lab.xml EX-101.LAB 15859
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20211213_pre.xml EX-101.PRE 12023
27 EXTRACTED XBRL INSTANCE DOCUMENT navb20211212_8k_htm.xml XML 2655
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 211486975
SIC: 2835 In Vitro & In Vivo Diagnostic Substances